论文部分内容阅读
经导管动脉栓塞（TAE）和经皮乙醇注射（PEI）已广泛用于治疗肝细胞癌（HCC）病人。前者用作治疗进展期HCC，后者用作治疗小HCC。PEI治疗小HCC后病人的存活率很高，但大损害作PEI后肿瘤的局部复发率高。作者介绍了TAE和PEI联合治疗大HCC损害的经验。83例不能切除的大HCC损害病
Transcatheter arterial embolization (TAE) and percutaneous ethanol injection (PEI) have been widely used to treat patients with hepatocellular carcinoma (HCC). The former is used to treat advanced HCC, and the latter is used to treat small HCC. The survival rate of patients after PEI treatment of small HCC is very high, but the local recurrence rate of tumors after large damage is PEI is high. The authors described the experience of TAE and PEI in the treatment of large HCC lesions. 83 cases of unresectable large HCC lesions